JBM  Vol.5 No.12 , December 2017
Folic Acid Supplementation Ameliorates Inflammation and Apoptosis in Ethanol-Induced Gastric Ulceration in Rats
Abstract: Although the gastroprotective potential of folic acid has been reported, little is known about the role of inflammation and apoptosis in the said activity. This study, therefore, assessed lipid peroxidation (LPO), Neutrophil-lymphocyte ratio (NLR), C-reactive protein (CRP) as markers of inflammation and, p53 and BCl-2 as markers of apoptosis in ethanol-induced gastric ulcer pretreated with Folic acid (FA) for twenty-one (21) days. Adult male Wistar rats were arranged into experimental groups (n = 5) viz: 1) Control; 2) Ulcer control; 3) 2FA (2 mg/kg folic acid + Ulcer); 4) 3FA (3 mg/kg folic acid + Ulcer); 5) OMEP (20 mg/kg omeprazole + Ulcer); 6) 2FA + OMEP + Ulcer; and 7) 3FA + OMEP + Ulcer. Ulcer score, LPO, NLR, serum CRP were all determined one hour post ulcer induction. Paraffin gastric sections were stained first with H & E, then immunostained for p53 and BCl-2. Ethanol caused gastric lesion with an index of 3.0 ± 0.2. Ulcer severity and LPO was significantly decreased in the 2FA, 3FA, OMEP, 2FA + OMEP and 3FA + OMEP groups. NLR reduced significantly in the 2FA, 3FA, OMEP and OMEP + 3FA group. Qualitatively, there was absence of C-reactive protein in the 2FA group while quantitatively, presence of CRP appeared sustained in the 3FA and OMEP treated groups. Unlike p53, the expression and labeling index of BCl-2 were significantly enhanced more in the FA and OMEP combination than OMEP alone. Folic acid ameliorates the development of gastric ulcer in rats via its anti-inflammatory and anti-apoptotic activities.
Cite this paper: Ajeigbe, K. , Jaja, L. , Onifade, A. , Obabueki, P. and Owonikoko, W. (2017) Folic Acid Supplementation Ameliorates Inflammation and Apoptosis in Ethanol-Induced Gastric Ulceration in Rats. Journal of Biosciences and Medicines, 5, 101-117. doi: 10.4236/jbm.2017.512011.

[1]   Wallace, J.L., Arfors, K.E. and McKnight, G.W. (1991) A Monoclonal Antibody against the CD18 Leukocyte Adhesion Molecule Prevents Indomethacin-Induced Gastric Damage in the Rabbit. Gastroenterology, 100, 878-883.

[2]   Tulassay, Z. and Herszényi, L. (2010) Gastric Mucosal Defense and Cytoprotection. Best Practice & Research Clinical Gastroenterology, 24, 99-108.

[3]   Allen, A. and Garner, A. (1980) Progress Report: Mucus and Bicarbonate Secretion in the Stomach and Their Possible Role in Mucosal Protection. Gut, 21, 249-262.

[4]   Wallace, J.L. and Granger, D.N. (1996) The Cellular and Molecular Basis of Gastric Mucosal Defense. FASEB Journal, 10, 731-740.

[5]   Herbay, A.V. and Rudi, J. (2000) Role of Apoptosis in Gastric Epithelial Turnover. Microscopy Research and Technique, 48, 303-311.<303::AID-JEMT7>3.0.CO;2-X

[6]   Yamaguchi, T., Nakajima, N., Kuwayama, H., Ito, Y., Iwasaki, A. and Arakawa, Y. (2000) Gastric Epithelial Cell Proliferation and Apoptosis in Helicobacter Pylori-Infected Mice. Alimentary Pharmacology & Therapeutics, 14, 68-73.

[7]   Arab, H.H., Salama, S.A., Omar, H.A., Arafa, E.S.A. and Maghrabi, I.A. (2015) Diosmin Protects against Ethanol-Induced Gastric Injury in Rats: Novel Anti-Ulcer Actions. PLoS ONE, 10, e0122417.

[8]   Cao, D.Z., Sun, W.H., Ou, X.L., Yu, Q., Yu, T., Zhang, Y.Z., et al. (2005) Effects of Folic Acid on Epithelial Apoptosis and Expression of Bcl-2 and p53 in Premalignant Gastric Lesions. World Journal of Gastroenterology, 11, 1571-1576.

[9]   Nicola, L.J., Andrew, S.D., Hilary, A.J. and Philip, M.S. (1999) Helicobacter pylori Induce Gastric Epithelial Cell Apoptosis in Association with Increased Fas Receptor Expression. Infection and Immunity, 67, 4237-4242.

[10]   Konturek, P., Faller, P. and Marlicz, K. (1999) Antigastric Autoantibodies in Helicobacter pylori Infected Patients with Gastric Carcinoma: Implication of Plasma Gastrin Release and Gastric Secretory Functions. Gastroenterology, 116, A218.

[11]   Nneli, R.O., Nwafia, W.C. and Oji, J.O. (2007) Diets/Dietary Habits and Certain Gastrointestinal Disorders in the Tropics: A Review. Nigerian Journal of Physiological Sciences, 22, 1-13.

[12]   Li, Z., Zou, D., Ma, X., Chen, J., Shi, X., Gong, Y., Man, X. and Gao, L. (2010) Epidemiology of Peptic Ulcer Disease: Endoscopic Results of the Systematic Investigation of Gastrointestinal Disease in China. American Journal of Gastroenterology, 105, 2570-2577.

[13]   Nwokediuko, S.C., Ijoma, U., Obienu, O. and Picardo, N. (2012) Time Trends of Upper Gastrointestinal Diseases in Nigeria. Annals of Gastroenterology, 25, 52-56.

[14]   Thorsen, K., Soreide, J.A., Kvaloy, J.T., Glomsaker, T. and Soreide, K. (2013) Epidemiology of Perforated Peptic Ulcer: Age- and Gender-Adjusted Analysis of Incidence and Mortality. World Journal of Gastroenterology, 19, 347-354.

[15]   Niv, Y. (2008) Hpylori Recurrence after Successful Eradication. World Journal of Gastroenterology, 14, 1477-1478.

[16]   Ito, T., Cadiot, G. and Jensen, R.T. (2012) Diagnosis of Zollinger-Ellison Syndrome: Increasingly Difficult. World Journal of Gastroenterology, 18, 5495-5503.

[17]   Wilhelm, M.S., Ryan, R.G. and Kale-Pradhan, P.B. (2013) Perils and Pitfalls of Long Term Effects of Proton Pump Inhibitors. Expert Review of Clinical Pharmacology, 6, 443-451.

[18]   Pereira, R.S. (2006) Regression of Gastroesophageal Reflux Disease Symptoms using Dietary Supplementation with Melatonin, Vitamins and Amino Acids: Comparison with Omeprazole. Journal of Pineal Research, 14, 195-200.

[19]   Celinski, K., Konturek, P.C., Konturek, S.J., Slomka, M., Cicoz-Lach, H., Brozozowski, T. and Bielanski, W. (2011) Effects of Melatonin and Tryptophan on Healing of Gastric and Duodenal Ulcers with Helicobacter pylori Infection in Humans. Journal of Physiology and Pharmacology, 62, 521-526.

[20]   Kim, Y.I. (2003) Role of Folate in Cancer Development and Progression. Journal of Nutrition, 133, 3731S-3739S.

[21]   Temple, C.T. and Montgomery, J.A. (1984) Chemical and Physical Properties of Folic acid and Reduced Derivatives. In: Blackey, R.L. and Benkovic, S.J., Eds., Folates and Pterins, Vol. 1, Chemistry and Biochemistry of Folates, 2nd Edition, John Wiley and Sons, New York, 61-120.

[22]   Lucock, M. (2004) Is Folic Acid the Ultimate Food Component for Disease Prevention? BMJ, 328, 211-214.

[23]   Ajeigbe, K.O., Olaleye, S.B., Oladejo, E.O. and Olayanju, A.O. (2011) Effect of Folic Acid Supplementation on Oxidative Gastric Mucosa Damage and Acid Secretory Response in the Rat. Indian Journal of Pharmacology, 43, 578-581.

[24]   Ajeigbe, K.O., Oladejo, E.O., Emikpe, B.O., Asuk, A.A. and Olaleye, S.B. (2012) The Dual Modulatory Effect of Folic Acid Supplementation on Indomethacin Induced Gastropathy. The Turkish Journal of Gastroenterology, 23, 639-645.

[25]   Haule, E.E., Moshi, M.J., Nondo, R.S., Mwangomo, D.T. and Mahunnah, R.L. (2012) A Study of Antimicrobial Activity, Acute Toxicity and Cytoprotective Effect of a Polyherbal Extract in a Rat Ethanol-HCl Gastric Ulcer Model. BMC Research Notes, 5, 546.

[26]   Gutteridge, J.M.C. and Wilkins, S. (1982) Copper-Dependent Hydroxyl Radical Damage to Ascorbic Acid: Formation of a Thiobarbituric Acid Reactive Product. FEBS Letters, 137, 327-330.

[27]   Hunter, G.D., Millson, G.C. and Chandler, R.L. (1963) Observations on the Comparative Infectivity of Cellular Fractions Derived from Homogenates of Mouse-Scrapie Brain. Research in Veterinary Science, 4, 543-549.

[28]   Ogihara, Y. and Okabe, S. (1993) Effect and Mechanism of Sucralfate on Healing of Acetic Acid-Induced Gastric Ulcers in Rats. Journal of Physiology and Pharmacology, 44, 109-118.

[29]   Haber, M.M. and Lopez, I. (1999) Gastric Histologic Findings in Patients with Nonsteroidal Anti-Inflammatory Drug-Associated Gastric Ulcer. Modern Pathology, 12, 592-598.

[30]   Trevethick, M.A., Clayton, N.M., Strong, P. and Harman, I.W. (1993) Do Infiltrating Neutrophils Contribute to the Pathogenesis of Indomethacin Induced Ulceration of the Rat Gastric Antrum? Gut, 34, 156-160.

[31]   Wang, J., Fan, X., Lindholm, C., Bennett, M., O’Connoll, J., Shanahan, F., et al. (2000) Helicobacter pylori Modulates Lymphoepithelial Cell Interactions Leading to Epithelial Cell Damage through Fas/Fas Ligand Interactions. Infect Immunity, 68, 4303-4311.

[32]   Yuan, Y., Padol, I.T. and Hunt, R.H. (2006) Peptic Ulcer Disease Today. Nature Clinical Practice Gastroenterology & Hepatology, 3, 80-89.

[33]   Piotrowski, J., Piotrowski, E., Skrodzka, D., Slomiany, A. and Slomiany, B.L. (1997) Gastric Mucosal Apoptosis Induced by Ethanol: Effect of Antiulcer Agents. Biochemistry and Molecular Biology International, 42, 247-254.

[34]   Lind, T., Cederberg, C., Ekenved, G., Haglund, U. and Olbe, L. (1983) Effect of Omeprazole—A Gastric Proton Pump Inhibitor on Pentagastrin Stimulated Acid Secretion in Man. Gut, 24, 270-276.

[35]   Tsuji, S., Sun, W., Tsujii, M., Kawai, N., Kimura, A., Kakiuchi, Y., Yasumaru, S., Komori, M., Murata, H., Sasaki, Y., Kawano, S. and Hor, M. (2002) Lansoprazole Induces Mucosal Protection through Gastrin Receptor-Dependent Up-Regulation of Cyclooxygenase-2 in Rats. Journal of Pharmacology and Experimental Therapeutics, 303, 1301-1308.

[36]   Tang, R.S.Y. and Wu, J.C.Y. (2013) Managing Peptic Ulcer and Gastroesophageal Reflux Disease in Elderly Chinese Patients-Focus on Esomeprazole. Clinical Interventions in Aging, 8, 1433-1443.

[37]   Kobayashi, T., Ohta, Y., Yoshino, J. and Nakazawa, T. (2001) Teprenone Promotes the Healing of Acetic Acid-Induced Chronic Gastric Ulcers in Rats by Inhibiting Neutrophil Infiltration and Lipid Peroxidation in Ulcerated Gastric Tissues. Pharmacological Research, 43, 23-30.

[38]   Musumba, C., Pritchard, D.M. and Pirmohamed, M. (2009) Cellular and Molecular Mechanisms of NSAIDs-Induced Peptic Ulcers. Alimentary Pharmacology & Therapeutics, 30, 517-531.

[39]   Dovi, J.V., Szpaderska, A.M. and Dipietro, L.A. (2004) Neutrophil Function in the Healing Wound: Adding Insult to Injury. Thrombosis and Haemostasis, 92, 275-280.

[40]   Nagatomi, R. (2006) The Implication of Alterations in Leukocyte Subset Counts on Immune Function. Exercise Immunology Review, 12, 54-71.

[41]   De Jager, C.P., Wijk, P.T., Mathoera, R.B., De Jongh-Leuvenink, J., Poll, V.T. and Wever, P.C. (2010) Lymphocytopenia and Neutrophil-Lymphocyte Count Ratio Predict Bacteremia Better than Conventional Infection Markers in an Emergency Care Unit. Critical Care, 14, R192.

[42]   Huang, G., Zhong, X.N. and Zhong, B. (2009) Significance of White Blood Cell Count and Its Subtypes in Patients with Acute Coronary Syndrome. European Journal of Clinical Investigation, 39, 348-358.

[43]   Jafarzadeh, A., Akbarpoor, V., Nabizadeh, M., Nemati, M. and Rezayati, M.T. (2013) Total Leukocyte Counts and Neutrophil-Lymphocyte Count Ratios among Helicobacter Pylori-Infected Patients with Peptic Ulcers: Independent of Bacterial CagA Status. The Southeast Asian Journal of Tropical Medicine and Public Health, 44, 82-88.

[44]   Ubukata, H., Motohashi, G., Tabuchi, T., Nagata, H. and Konishi, S. (2010) Evaluations of Interfer-on-Gamma/Interleukin-4 Ratio and Neutrophil/Lymphocyte Ratio as Prognostic Indicators in Gastric Cancer Patients. Journal of Surgical Oncology, 102, 742-747.

[45]   Droogendijk, J., Beukers, R., Berendes, P.B., Tax, M.G., Sonneveld, P. and Levin, M.D. (2011) Screening for Gastrointestinal Malignancy in Patients with Iron Deficiency Anemia by General Practitioners: An Observational Study. Scandinavian Journal of Gastroenterology, 46, 1105-1110.

[46]   Boehme, M.W., Autschbach, F., Ell, C. and Raeth, U. (2007) Prevalence of Silent Gastric Ulcer, Erosions or Severe Acute Gastritis in Patients with Type 2 Diabetes Mellitus—A Cross-Sectional Study. Hepatogastroenterol, 54, 643-648.

[47]   Hawley, T.S., Burns, B.F. and Hawley, R.G. (1991) Leukocytosis in Mice Following Long-Term Reconstitution with Genetically-Modified Bone Marrow Cells Constitutively Expressing Interleukin 1 Alpha or Interleukin 6. Leukemia Research, 15, 659-673.

[48]   Wu, C.W., Wang, S.R., Chao, M.F., Wu, T.C., Lui, W.Y., P’eng, F.K. and Chi, C.W. (1996) Serum Interleukin-6 Levels Reflect Disease Status of Gastric Cancer. The American Journal of Gastroenterology, 91, 1417-1422.

[49]   Szabo, I. and Tarnawski, A.S. (2000) Apoptosis in Gastric Mucosa: Molecular Mechanisms, Basic and Clinical Implications. Journal of Physiology and Pharmacology, 51, 3-15.

[50]   Stachura, J., Tarnawski, A. and Dabros, W. (1993) Apoptosis: Genetically Programmed Physiological Cell Loss in Normal Gastric Oxyntic Mucosa and in Mucosa of Grossly Healed Gastric Ulcer. Journal of Clinical Gastroenterology, 17, S70-S77.